Abstract Details
|
Daniel Winkel, MD
(Emory University)
PRESENTER |
The institution of Dr. Winkel has received research support from NextSense, Inc. |
| Ahmed Enayetallah, PhD, MBBCh (BlueRock Therapeutics) | Dr. Enayetallah has received personal compensation for serving as an employee of Alexion. Dr. Enayetallah has received stock or an ownership interest from Alexion. Dr. Enayetallah has received stock or an ownership interest from AstraZeneca. |